AstraZeneca Plc

(AZNCF)

By |

Profile

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology, and neuroscience. The majority of sales come from international markets with the United States representing almost 30% of its sales.

Contact Information

Website: www.astrazeneca.com
Email: ir@astrazeneca.com
Main Phone: +44 2037495000
Address: 1 Francis Crick Avenue
Address 2: Cambridge Biomedical Campus
City / Town: Cambridge
Country: GBR
Postal Code: CB2 0AA

Issuer Information

Exchange: OTO
CEO: Pascal Soriot
Employees: 61100
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 78.40 $ 0. (0.00%)
Last Price 78.40 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 78.40
Last Trade Volume 0 52 Wk Hi 82.60 52 Wk Low 62.82
Market Cap 99.3 bi Ex-Div Date Div Rate 1.80 Yield 2.2960
Shares 1,266,811,703.00 EPS (TTM) 1.91 PE Ratio 40.90 Exchange OTCPK